Guided Therapeutics (GTHP) Preferred Dividend Payments (2013 - 2025)
Guided Therapeutics recorded quarterly Preferred Dividend Payments of $24000.0 in Q4 2025, down 44.19% quarter-over-quarter from $43000.0 in Q3 2025, and down 50.0% year-over-year from $48000.0 in Q4 2024.
Guided Therapeutics' Preferred Dividend Payments history runs 13 years deep, the most recent figure standing at $24000.0 for Q4 2025.
- In Q4 2025, Preferred Dividend Payments fell 50.0% year-over-year to $24000.0; the TTM figure through Dec 2025 stood at $148000.0 (down 14.94% YoY), while the FY2025 annual figure was $150000.0, down 13.79% from the prior year.
- Preferred Dividend Payments came in at $24000.0 for Q4 2025 at Guided Therapeutics, down from $43000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $548000.0 in Q1 2022 to a low of -$55000.0 in Q1 2021.
- A 5-year average of $73700.0 and a median of $47500.0 in 2022 frame the typical range for Preferred Dividend Payments.
- Across the five-year window, Preferred Dividend Payments slumped 558.33% in 2021 and soared 1096.36% in 2022, its largest moves.
- Guided Therapeutics' Preferred Dividend Payments stood at $65000.0 in 2021, then fell by 23.08% to $50000.0 in 2022, then decreased by 2.0% to $49000.0 in 2023, then declined by 2.04% to $48000.0 in 2024, then sank by 50.0% to $24000.0 in 2025.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $24000.0, $43000.0, and $45000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 47,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 81,000.00 |
| Mar 31, 2022 | 548,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Jun 30, 2021 | 125,000.00 |
| Mar 31, 2021 | -55,000.00 |
| Dec 31, 2020 | -197,000.00 |
| Sep 30, 2020 | 46,000.00 |
| Jun 30, 2020 | 17,000.00 |
| Mar 31, 2020 | 12,000.00 |
| Jun 30, 2019 | -9,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Dec 31, 2018 | 8,000.00 |
| Sep 30, 2018 | 11,000.00 |
| Jun 30, 2018 | 42,000.00 |
| Mar 31, 2018 | 55,000.00 |
| Dec 31, 2017 | 62,000.00 |
| Sep 30, 2017 | 52,000.00 |
| Jun 30, 2017 | 66,000.00 |
| Mar 31, 2017 | 99,000.00 |
| Dec 31, 2016 | 84,000.00 |
| Sep 30, 2016 | 179,000.00 |
| Jun 30, 2016 | 292,000.00 |
| Mar 31, 2016 | 470,000.00 |
| Dec 31, 2015 | -533,000.00 |
| Sep 30, 2015 | 545,000.00 |
| Jun 30, 2015 | -1.30 Mn |
| Mar 31, 2015 | -31,000.00 |
| Dec 31, 2014 | -24,000.00 |
| Sep 30, 2014 | -39,000.00 |
| Jun 30, 2014 | -41,000.00 |
| Mar 31, 2014 | -48,000.00 |
| Dec 31, 2013 | 1.17 Mn |
| Jun 30, 2013 | -1.17 Mn |